A new species of Myxobolus (Cnidaria: Myxosporea: Myxobolidae) from the gills of the green sunfish, Lepomis cyanellus (Perciformes: Centrarchidae), from the Ouachita River Drainage of Western Arkansas.

Forty-two species of myxozoans, including 31 species of Myxobolus Bütschli, 1882, have been described from centrarchid fishes. One species, the green sunfish (Lepomis cyanellus), has been reported to host at least three species of Myxobolus. Between March 2023 and June 2024, 42 L.

A new species of Choleoeimeria (Apicomplexa: Eimeriidae) from the invasive curious skink, Carlia ailanpalai (Sauria: Scincidae) from Guam, U.S. Territory.

The curious skink, Carlia ailanpalai Zug, occurs in the main group of the Admiralty Islands of Papua New Guinea but has also successfully invaded Guam, the Marianas, Yap, and Kosrae. A single coccidian, Eimeria zugi McAllister, Duszynski, Fisher, & Austin, 2013 was described from C. ailanpalai from Papua New Guinea.

Octomacrum spinum (Monogenoidea: Polyopisthocotylea: Octomacridae) from highland stoneroller, Campostoma spidaceum (Cypriniformes: Leuciscidae) from Arkansas and Oklahoma, USA, with a summary of the genus from North American and European fishes.

Octomacrum spinum Dansby & Shoemaker, 1973, is reported for the first time from 23 of 146 (16%) highland stonerollers, Campostoma spadiceum collected from central and western Arkansas and southeastern Oklahoma, USA. Analysis of molecular data revealed that the SSU rRNA gene of specimens of O. spinum from Arkansas was identical to a number of Octomacrum spp.

Safe and effective in vivo delivery of DNA and RNA using proteolipid vehicles.

Genetic medicines show promise for treating various diseases, yet clinical success has been limited by tolerability, scalability, and immunogenicity issues of current delivery platforms. To overcome these, we developed a proteolipid vehicle (PLV) by combining features from viral and non-viral approaches. PLVs incorporate fusion-associated small transmembrane (FAST) proteins isolated from fusogenic orthoreoviruses into a well-tolerated lipid formulation, using scalable microfluidic mixing.